Klinisk Biokemi i Norden · 3 2019
| 19
22. Zhang X, Liu C, Guo J, Song Y. Selenium sta-
tus and cardiovascular diseases: meta-analysis
of prospective observational studies and ran-
domized controlled trials. Eur J Clin Nutr
2016;70(2):162-9.
23. Kuria A, Fang X, Li M, Han H, He J, Aaseth JO,
et al. Does dietary intake of selenium protect
against cancer? A systematic review and meta-
analysis of population-based prospective studies.
Crit Rev Food Sci Nutr 2018:1-11.
24. Cai X, Wang C, Yu W, Fan W, Wang S, Shen N,
et al. Selenium Exposure and Cancer Risk: an
UpdatedMeta-analysis andMeta-regression. Sci
Rep 2016;6:19213.
25. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turn-
bull BW, Slate EH, Jacobs ET, et al. Selenium
supplementation, baseline plasma selenium sta-
tus and incidence of prostate cancer: an ana-
lysis of the complete treatment period of the
Nutritional Prevention of Cancer Trial. BJU Int
2003;91(7):608-12.
26. Lippman SM, Klein EA, Goodman PJ, Lucia MS,
Thompson IM, Ford LG, et al. Effect of sele-
nium and vitamin E on risk of prostate cancer
and other cancers: the Selenium and Vitamin
E Cancer Prevention Trial (SELECT). JAMA
2009;301(1):39-51.
27. Epplein M, Burk RF, Cai Q, Hargreaves MK,
Blot WJ. A prospective study of plasma Seleno-
protein P and lung cancer risk among low-
income adults. Cancer Epidemiol Biomarkers
Prev 2014;23(7):1238-44.
28. Persson-Moschos ME, Stavenow L, Akesson B,
Lindgarde F. Selenoprotein P in plasma in rela-
tion to cancer morbidity inmiddle-aged Swedish
men. Nutr Cancer 2000;36(1):19-26.
29. Pinto JT, Lee JI, Sinha R, MacEwanME, Cooper
AJ. Chemopreventive mechanisms of alpha-
keto acid metabolites of naturally occurring
organoselenium compounds. Amino Acids
2011;41(1):29-41.
30. Ho E, Beaver LM, Williams DE, Dashwood RH.
Dietary factors and epigenetic regulation for pro-
state cancer prevention. AdvNutr 2011;2(6):497-510.
Foto: Henrik Alfthan.
